The gastrointestinal tract is a passageway for dietary nutrients, microorganisms and xenobiotics. The gut is home to diverse bacterial communities forming the microbiota. While bacteria and their metabolites maintain gut homeostasis, the host uses innate and adaptive immune mechanisms to cope with the microbiota and luminal environment. In recent years, multiple bi-directional instructive mechanisms between microbiota, luminal content and mucosal immune systems have been uncovered. Indeed, ep...
An important aspect of many chemical antibacterials is their breadth of action. This is a positive aspect because it can allow antibiotic application prior to determination of the antibiotic susceptibility of a pathogen. This property, however, is a double-edged sword, since non-target as well as target bacteria are impacted by such broad-spectrum antibiotics. The result can be dysbiosis, that is, a negative impact on important normal bacterial flora. One result of antibiotic usage consequently can be antibiotic-associated superinfections, such as vaginal yeast infections or Clostridium difficile-associated colitis. Most phages, by contrast, possess only narrow spectra of activity: Even when phages are mixed into cocktails, their overall activity spectrum remains relatively narrow. The result is a lower potential for side effects associated with dysbiosis, a phenomenon that does not appear to be a concern associated with phage therapy. [1]
Blockade of programmed death 1 (PD-1) pro...
READ MORE→
A search of the published medical literature revealed
1 study investigating the researchable question:
What are therapeutic alternatives for What are therapeutic alternatives for Erythromycin Ointment - Ointment, 5 mg/1 g??
Level of evidence
B - One high-quality study or multiple studies with limitations
READ MORE→
[1] Hosseinzadeh R, Feizisani F, Shomali N, Abdelbasset WK, Hemmatzadeh M, Gholizadeh Navashenaq J, Jadidi-Niaragh F, Bokov DO, Janebifam M, Mohammadi H. IUBMB Life. 2021 Nov;73(11):1293-1306. doi: 10.1002/iub.2558.
[2] Fang XN, Fu LW. Recent Pat Anticancer Drug Discov. 2016;11(2):141-51. doi: 10.2174/1574892811666160226150506.